Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).
Barnett, J A
Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP). [electronic resource] - British journal of clinical pharmacology Feb 1989 - 257-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0306-5251
10.1111/j.1365-2125.1989.tb05358.x doi
Adult
Aged
Humans
Male
Middle Aged
Neoplasms--blood
Orosomucoid--metabolism
Protein Binding
Quinidine--metabolism
Recombinant Proteins
Tumor Necrosis Factor-alpha--therapeutic use
Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP). [electronic resource] - British journal of clinical pharmacology Feb 1989 - 257-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0306-5251
10.1111/j.1365-2125.1989.tb05358.x doi
Adult
Aged
Humans
Male
Middle Aged
Neoplasms--blood
Orosomucoid--metabolism
Protein Binding
Quinidine--metabolism
Recombinant Proteins
Tumor Necrosis Factor-alpha--therapeutic use